Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics

PartnershipPositive

AI Analysis

Summary

Rznomics Inc., a South Korean RNA-based gene therapy company, has joined Eli Lilly's Lilly Gateway Labs in San Diego to accelerate development of RNA therapeutics. This collaboration represents a strategic partnership between Rznomics and Lilly to advance RNA therapeutic programs.

Importance:6/10

Sentiment:

0.60

partnershipRNA therapeuticsgene therapyLilly Gateway LabsSan Diegocollaboration

Related Companies

$LLY

Read the original article

Published by PR Newswire Clinical Trials on August 24, 2026 1:54 AM

Read Original